Formosa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Formosa Pharmaceuticals has a total shareholder equity of NT$1.6B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$2.1B and NT$545.6M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.66b |
| Equity | NT$1.60b |
| Total liabilities | NT$545.58m |
| Total assets | NT$2.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6838's short term assets (NT$1.7B) exceed its short term liabilities (NT$187.5M).
Long Term Liabilities: 6838's short term assets (NT$1.7B) exceed its long term liabilities (NT$358.1M).
Debt to Equity History and Analysis
Debt Level: 6838 is debt free.
Reducing Debt: 6838 has no debt compared to 5 years ago when its debt to equity ratio was 1.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6838 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6838 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 0.7% each year